Process Flow Outlining the Mechanisms of Immune-Mediated Liver Damage: Comprehensive Analysis of T-Cell Activity and Autoantibody Contributions in Hepatocellular Injury

Immune-mediated liver damage represents a complex pathophysiological process involving intricate interactions between adaptive immune responses and hepatic tissue destruction. This comprehensive review elucidates the sequential mechanisms underlying immune-mediated hepatocellular injury, with particular emphasis on T-cell-mediated cytotoxicity and autoantibody-driven pathogenesis. The process initiates through molecular mimicry or epitope spreading, leading to aberrant immune recognition of hepatic self-antigens. CD4+ T-helper cells differentiate into Th1 and Th17 subsets, secreting pro-inflammatory cytokines including interferon-γ, interleukin-17, and tumour necrosis factor-α, which orchestrate local inflammatory cascades. CD8+ cytotoxic T lymphocytes execute direct hepatocyte killing through perforin-granzyme and Fas-FasL pathways. Concurrently, activated B-cells produce pathogenic autoantibodies targeting intracellular and surface antigens, including anti-nuclear antibodies (ANA), anti-smooth muscle antibodies (ASMA), anti-liver kidney microsome antibodies (anti-LKM), and anti-mitochondrial antibodies (AMA). These autoantibodies mediate tissue damage through complement activation and antibody-dependent cellular cytotoxicity (ADCC). The convergence of T-cell-mediated and autoantibody-mediated effector mechanisms results in hepatocyte apoptosis, necrosis, and subsequent fibrotic remodelling. Understanding these mechanistic pathways provides crucial insights for therapeutic intervention in autoimmune liver diseases, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. This review synthesises current knowledge while explicitly excluding genetic predisposition factors to focus solely on immunological processes governing liver tissue destruction.